FATE FATE THERAPEUTICS INC Investor Conferences 8-K Filing 2023 - Presentation at Jefferies Healthcare Conference Fate Therapeutics will present at the 2023 Jefferies Healthcare Conference, providing an update on its FT522 program for B-cell lymphoma treatment.Get access to all SEC 8-K filings of the FATE THERAPEUTICS INC